| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 12.59B | — |
| Operating expense | — | — |
| Net income | 928.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ABL.F returned -9.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -3.4% |
| 1 year | -9.0% |
| 5 years | +3.7% |
| 10 years | +224.7% |
| All-time high | €130.00 (Feb 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ABL.F would be worth today ›Yes. Abbott Laboratories paid 4 dividends over the past 12 months. The most recent was €0.54 per share on Jul 15, 2026. The dividend yield is 2.18%.
Abbott Laboratories is part of the Healthcare sector.
Abbott Laboratories has a market cap of 172.66B EUR, based on the latest quote.
Abbott Laboratories is expected to report earnings around Oct 14, 2026. That date is an estimate and has not been confirmed by the company.